ACTOS – pioglitazone

Diabetes drug being investigated for potentially fatal bladder cancer risk

ACTOS is the brand name of a drug developed by Takeda Pharmaceuticals in conjunction with Eli Lilly and Company. The drug is designed to help control blood sugar levels in patients with Type 2 Diabetes. The generic name of the drug is pioglitazone.

Sheller attorneys are investigating the serious and potentially fatal risks of ACTOS. Contact the firm at 800-883-2299.

NEWS UPDATE: Actos manufacturer Takeda is said to have agreed to a $2.2 billion settlement for patients harmed by the drug

What is the FDA warning?

The FDA released a drug safety update in June 2011 warning doctors and patients of the potential link between the drug ACTOS and bladder cancer, particularly in patients who’ve taken the drug for more than one year. Based on a study conducted in France, both France and Germany have suspended or limited the use of ACTOS.

What are the symptoms that may indicate you are at risk?

If you take or have taken ACTOS and have experienced these symptoms, consult your health care provider immediately:

  • Blood in the urine
  • Urgent need to urinate
  • Pain while urinating
  • Frequent urination, or feeling the need to urinate but with no results
  • Pain in the abdominal (stomach) area or in the back

If you have a diagnosis of bladder cancer and have been taking ACTOS for more than one year, contact us now by calling 800-883-2299, filling out the form on this page or e-mailing us for a no obligation consultation about your legal rights.

Links

FDA Drug Safety Review Update, June 2011

Takeda Offers $2.2 Billion to Settle Actos Drug Cases, Bloomberg News, March 31, 2015